Abstract
The Churg—Strauss Syndrome (CSS) is a form of necrotizing vasculitis characterized by eosinophilic infiltration of small- and medium-sized blood vessels. The initial disease manifestation is usually the development of asthma in an individual who did not suffer previously from reactive airway disease. Allergic rhinitis is another manifestation of atopy, often identified in retrospect as the first sign of CSS. The extra-pulmonary organs commonly involved in the CSS are the peripheral nerves, skin, joints, and heart. The brain, eyes, gastrointestinal tract, and kidneys are involved less often. Vasculitic neuropathy occurs in 80% of patients with CSS and can lead to devastating complications through paralysis of the distal extremities. Nerve infarctions generally lead to an asymmetric, axonal sensorimotor neuropathy. The clinical features of CSS overlap in many ways on those of two other forms of necrotizing vasculitis, Wegener's granulomatosis, and microscopic poly-angiitis. However, patients with CSS are less likely to have antineutrophil cytoplasmic antibodies (ANCA) than those with other conditions. When patients with CSS are ANCA-positive, the antigen specificity is directed more often against myeloperoxidase than against serine proteinase-3. Anti-myeloperoxidase ANCA produces a perinuclear (“P-ANCA”) pattern of staining in immunofluorescence studies of serum. CSS must be distinguished from a group of non-vasc-ulitic conditions associated with hypereosinophilia. Among these are the hypereosinophil syndrome, eosinophilic leukemia, eosinophilic fasciitis, and parasitic infections.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Boin F, Sciubba JJ, Stone JH. Churg-Strauss syndrome presenting with salivary gland enlargement and respiratory distress. Arthritis Rheum 2006; 55:167–170
Churg A. Recent advances in the diagnosis of Churg-Strauss syndrome. Mod Pathol 2001; 14:1284–1293
Churg A. Churg-Strauss syndrome, microscopic polyangiitis, and other forms of pulmonary vasculitis. In: Churg A, Myers J, Tazelaar H, Wright JL (eds) Thurlbeck's pathology of the lung (3rd edn). New York, Thieme Medical Publishers, 2005, pp. 391–412
Churg J, Strauss L. Allergic granulomatosis, allergic angiitis, and peri-arteritis nodosa. Am J Pathol 1951; 27:277–301
Clutterbuck E, Evans D, Pusey C. Renal involvement in Churg-Strauss syndrome. Nephrol Dial Transplant 1990; 5:161–167
Dahabreh IJ, Giannouli S, Zoi C, et al Management of hypereosino-philic syndrome: A prospective study in the era of molecular genetics. Medicine (Baltimore) 2007; 86(6):344–354
Godman G, Churg J. Wegener's granulomatosis: Pathology and review of the literature. Arch Pathol Lab Med 1954; 58:533–551
Guillevin L, Cohen P, Gayraud M, et al Churg-Strauss syndrome: Clinical study and long-term follow-up of 96 patients. Medicine (Baltimore) 1999; 78:26–37
Keogh KA, Specks U. Churg-Strauss syndrome: Clinical presentation, antineutrophil cytoplasmic antibodies, and leukotriene receptor antagonists. Am J Med 2003; 115:284–290
Lanham JG, Elkon KB, Pusey CD, Hughes GRV. Systemic vasculitis with asthma and eosinophilia: A clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore) 1984; 63:65–81
Mathew L, Talbot K, Love S, et al Treatment of vasculitic peripheral neuropathy: A retrospective analysis of outcome. Q J Med 2007; 100:41
Pagnoux C, Guilpain P, Guillevin L. Churg-Strauss syndrome. Curr Opin Rheumatol 2007; 19:25–32
Rothenberg ME, Klion AD, Roufosse FE, et al Treatment of patients with the hypereosinophilic syndrome with mepolizumab. N Engl J Med 2008; 358(12):1215–1228
Sablé-Fourtassou R, Cohen P, Mahr A, et al Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome. Ann Intern Med 2005; 143:632–638
Sinico RA, Di Toma L, Maggiore U, et al Prevalence and clinical sig-nificance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome. Arthritis Rheum 2005; 52: 2926–2935
Wechsler ME. Combating the eosinophil with anti-interkeukin-5 therapy. N Engl J Med 2008; 358(12):1293–1294
Wechsler ME, Finn D, Gunawardena D, et al Churg-Strauss syndrome in patients receiving montelukast as treatment for asthma. Chest 2000; 117:708–713
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Churg, A., Specks, U., Stone, J.H. (2009). The Churg—Strauss Syndrome. In: Stone, J.H. (eds) A Clinician's Pearls and Myths in Rheumatology. Springer, London. https://doi.org/10.1007/978-1-84800-934-9_23
Download citation
DOI: https://doi.org/10.1007/978-1-84800-934-9_23
Publisher Name: Springer, London
Print ISBN: 978-1-84800-933-2
Online ISBN: 978-1-84800-934-9
eBook Packages: MedicineMedicine (R0)